Search results for "Acute-On-Chronic Liver Failure"

showing 2 items of 2 documents

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis

2020

Introduction Frailty is a common but often underestimated complication in patients with liver cirrhosis. The Clinical Frailty Scale (CFS) allows the assessment of frailty within a short period of time but has only been investigated in a Canadian cohort of outpatients. The aim of the current study was to evaluate the ability of the CFS to predict mortality in outpatients and nonelectively hospitalized German patients. Methods Two hundred outpatients and 99 nonelectively hospitalized patients with liver cirrhosis were prospectively enrolled. Outpatients/inpatients were followed for a median of 364/28 days regarding the primary outcome of death or liver transplantation. Eighty-seven patients o…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosismedicine.medical_treatmentLiver transplantationMuscle massRisk AssessmentSeverity of Illness IndexArticle03 medical and health sciences0302 clinical medicineInternal medicineGermanymedicineHumansIn patientHospital MortalityProspective StudiesMuscle SkeletalAgedFrailtybusiness.industryHazard ratioGastroenterologyAcute-On-Chronic Liver FailureOdds ratioMiddle Agedmedicine.diseaseLiver TransplantationHospitalizationLiver030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleComplicationbusinessTomography X-Ray ComputedFollow-Up StudiesClinical and Translational Gastroenterology
researchProduct

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outs…

2021

Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AK…

MalePhysiologymedicine.medical_treatmentLiver transplantationToxicologyPathology and Laboratory MedicineSeverity of Illness IndexBiochemistrylaw.inventionBlood Urea Nitrogen0302 clinical medicinelawLiver Cirrhosis AlcoholicMedicine and Health SciencesMedicineBileMultidisciplinaryLiver DiseasesQRMiddle AgedIntensive care unitBody FluidsRenal Replacement TherapyLiverCirrhosisNephrologyCreatinineMedicine030211 gastroenterology & hepatologyFemaleHemodialysisAnatomyDetoxificationResearch Articlemedicine.medical_specialtyCritical CareScienceSurgical and Invasive Medical ProceduresGastroenterology and Hepatology03 medical and health sciencesDigestive System ProceduresRenal DialysisIntensive careInternal medicineAlbuminsMedical DialysisHumansRenal replacement therapyDialysisRetrospective StudiesTransplantationbusiness.industryAcute-On-Chronic Liver FailureBiology and Life SciencesProteins030208 emergency & critical care medicineRetrospective cohort studyBilirubinOrgan TransplantationSurvival AnalysisLiver TransplantationPatient ComplianceLiver functionbusinessBiomarkersPLoS ONE
researchProduct